InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
4
T+90 hit rate
60%
T+90 mean return
-4.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by PERRY MARK L, Director. Director active across 2 companies, notably NVIDIA CORP. Aggregated, 14 filings have been recorded. Split: 1 buy · 4 sells. Total volume traded: €18.7m. History available since 4 June 2021. The latest transaction was filed on 2 April 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations14 total
7,000 shares@ US$887.894230.8% of flowCommon StockSEC:0001045810-24-000090:0
15,000 shares@ US$796.446158.9% of flowCommon StockSEC:0001045810-24-000040:0
650 shares0Common StockSEC:0001045810-23-000154:0
2,000 shares0Common StockSEC:0001045810-23-000099:0
6,800 shares@ US$235.30898.1% of flowCommon StockSEC:0001045810-23-000024:0
37,865 sharesCommon StockSEC:0000899243-22-033162:0
3,600 sharesCommon StockSEC:0000899243-22-022903:0
1,438 shares0Common StockSEC:0001045810-22-000105:0
1,800 shares@ US$262.900.0000% mcap100.0% of flowCommon StockSEC:0001045810-22-000052:0
3,037 sharesCommon StockSEC:0000899243-21-024985
3,037 sharesCommon StockSEC:0000899243-21-024985:0
429 shares0Common StockSEC:0001045810-21-000092:0
429 shares0Common StockSEC:0001045810-21-000092
5,000 sharesCommon StockSEC:0000899243-16-011356:0
Ideal exit: 13 May 2016 (T+270)
14 of 14 declarations
About PERRY MARK L
Mark L. Perry is a Board Member at NVIDIA Corp and Global Blood Therapeutics, Inc. He is responsible for overseeing operations and strategic decision-making. His expertise in the technology and biopharmaceutical sectors helps guide growth and innovation initiatives.
